Peritonitis induced by ITO-NPs was diminished by impeding NLRP3 inflammasome activation by a sulfonylurea pharmacological inhibitor, glybenclamide (Gly) (Fig. 1d–g). This evidence concerns the gene NLRP3 and peritonitis.